Theravance Biopharma
TBPH
TBPH
100 hedge funds and large institutions have $1.27B invested in Theravance Biopharma in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 43 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+2
Holders Change %
+2.04%
% of All Funds
2.67%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
15
Increased
43
Reduced
23
Closed
12
Calls
$272K
Puts
$972K
Net Calls
-$700K
Net Calls Change
-$621K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SAM
101
Scion Asset Management
Saratoga,
California
| – | -$7.37M | -325,000 | Closed |
|
|
TC
102
TFS Capital
West Chester,
Pennsylvania
| – | -$1.09M | -47,803 | Closed |
|
103
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$479K | -21,100 | Closed |
|
104
Squarepoint
New York
| – | -$279K | -12,300 | Closed |
|
|
HI
105
HBK Investments
Dallas,
Texas
| – | -$218K | -9,598 | Closed |
|
|
EMG
106
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$209K | -9,200 | Closed |
|
107
Teacher Retirement System of Texas
Austin,
Texas
| – | -$111K | -4,887 | Closed |
|
108
Creative Planning
Overland Park,
Kansas
| – | -$23K | -1,000 | Closed |
|
109
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$8K | -334 | Closed |
|
|
TRCT
110
Tower Research Capital (TRC)
New York
| – | -$5K | -229 | Closed |
|